Health care software, analytics and payment service provider Emdeon plans to rename as Change Healthcare to better reflect its diverse capabilities and solutions. The company said late Thursday that the rebranding is slated to begin in the fourth quarter of this year.
Sandoz has inaugurated a new era in medicine with the release of Zarxio, the first biosimilar of a biologic drug approved in the United States. The Novartis subsidiary said Thursday that Zarxio — a biosimilar of Amgen Corp.
Par Pharmaceutical has released testosterone gel 1%, a generic version of AndroGel 1% from AbbVie. Par said Wednesday that its testosterone gel 1% product is available in 2.5g and 5g aluminum foil packets containing 25 mg or 50 mg of testosterone, respectively.
Lannett Co. plans to acquire Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic drug subsidiary of UCB S.A., in a $1.23 billion deal. Lannett said late Wednesday that the acquisition will add a diversified commercial product portfolio of 18 products.
Hershey Co. has made its Ice Breakers mints available via the Amazon Dash Button, a miniature device that makes it easier for consumers to reorder their favorite products.
Sandoz has launched a rivastigmine patch, a treatment for dementia, in the U.S. market. The Novartis subsidiary said Wednesday that its rivastigmine transdermal system is an authorized generic version of the Exelon patch, marketed by Novartis Pharmaceuticals Corp.
Sundial Brands, the maker of natural beauty care brands SheaMoisture and Nubian Heritage, has sold a minority interest in the company to global investment firm Bain Capital Private Equity.
J M Smith Corp. has acquired pharmacy-related technology products and services offered by Integra NV and will manage them as a subsidiary called Integra LTC Solutions LLC.
Sanofi and the life sciences team at Google have formed a collaboration to improve care and outcomes for people with type 1 and type 2 diabetes.
NeilMed Pharmaceuticals Inc. USA has rolled out the Naspira nasal-oral aspirator for babies and small children.
Perrigo Co. plc has acquired the ScarAway scar management brand from Enaltus LLC. Financial terms of the transaction weren’t disclosed. Perrigo said Monday that Scaraway is expected to generate overall 2015 net sales of $10 million, or approximately $3 million for the remainder of the year.
Early feedback on the Food and Drug Administration’s proposal on naming conventions for biosimilars shows a mixed response.
Head & Shoulders has signed up New York Giants wide receiver Odell Beckham as its latest hair ambassador. The Procter & Gamble hair care brand — the official shampoo of the National Football League — said Friday that fans can now see Beckham in his first ad for Head & Shoulders on the
Novo Nordisk plans to acquire Calibrium LLC and MB2 LLC, two privately held biopharmaceutical research companies based in Carmel, Ind.
Beauty care manufacturer and distributor American International Industries (A.I.I.) has acquired Hollywood Fashion Secrets, a brand of fashion and beauty accessories. Financial terms of the agreement, announced Thursday, weren’t disclosed.
Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for entecavir tablets 0.5 mg and 1 mg, a medication for hepatitis B. Aurobindo, which announced the product this week, said its entecavir tablets are a generic version of Baraclude tablets (0.
